APIC 2019 Annual Conference Wednesday, June 12 – 3:00 PM – 5:30 PM Pennsylvania Convention Center, 108B As the amount of legislation and regulation governing the practice of IPC increases, it becomes more important for policymakers to hear from experts to help guide them and provide advice on evidence-based practices that lead to increased patient … Continue reading “Finding Your Voice: Advocating for IPC”
Pharm D Solutions is voluntarily recalling all sterile compounded drug products due to concerns that practices at the pharmacy have the potential to pose a risk of contamination. Read more.
The FDA has authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood. The ZIKV Detect 2.0 IgM Capture ELISA is the first Zika diagnostic test the FDA has allowed to be marketed in the U.S. Previously, tests for detecting Zika virus IgM antibodies had been authorized only for emergency … Continue reading “FDA Authorizes Marketing of Diagnostic Test for Zika Antibodies”
The FDA approved marketing of the Synovasure Lateral Flow Test Kit as an aid for the detection of periprosthetic joint infection in the synovial fluid of patients being evaluated for revision surgery, which is surgery performed to replace or compensate for a failed implant. Read more.
The FDA is alerting hospitals, laboratories, and providers of a Class 1 recall of Beckman Coulter DxH 800, DxH 600 and DxH 900 hematology analyzers. Device users have reported inaccurate blood platelet counts, which could result in misdiagnosis of diseases and conditions such as anemia, infections, blood clotting problems, blood cancers, and immune system disorders. … Continue reading “Beckman Coulter Recalls Hematology Analyzers”
Ignoring warnings from the CDC and FDA, the U.S. Environmental Protection Agency (EPA) approved expanded use of streptomycin and oxytetracycline for the spraying of citrus crops. The approval will allow for up to 650,000 pounds of streptomycin to be used annually in agriculture, whereas humans in the US currently use 14,000 pounds of the antibiotic … Continue reading “EPA Allows Expanded Use of Antibiotics for Agriculture”
The FDA cleared the ERBEFLO 24-hour multipatient use port connector after a design modification added a backflow prevention feature to reduce the risk of cross-contamination of the irrigation system. The FDA clearance also required revised labeling to identify compatible endoscopes and accessories, as well as clear and specific warnings to assure proper use. Read more.
Heritage Pharmaceuticals has voluntarily recalled Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL), manufactured by Emcure Pharmaceuticals, due to detection of microbial growth in one lot which may indicate lack of sterility. Amikacin Sulfate Injection is indicated in the short-term treatment of serious infections due to susceptible strains of … Continue reading “Heritage Recalls Injections Due to Lack of Sterility”
APIC is taking strong steps to advocate for CMS to finalize proposed revisions to the Hospital/CAH Conditions of Participation (CoPs), which include the first update to infection prevention and control requirements since 1986 and includes a requirement for hospitals to establish antibiotic stewardship programs. Without further action, the proposed improvements will expire on June 16, … Continue reading “APIC increases advocacy for CMS CoPs and antibiotic stewardship programs”
The NHSN Biovigilance Team recently identified a defect in the Hemovigilance module that prevents users from submitting the Annual Facility Survey. On February 19, 2019 from 10am-1pm ET the module will be repaired to resolve the defect. The module will be unavailable for data entry during this time. While NHSN continues to fix this defect, … Continue reading “NHSN Hemovigilance Module defect identified”